• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

作者信息

Smith T J, Hillner B E, Desch C E

机构信息

Department of Medicine, Massey Cancer Center, Medical College of Virginia, Virginia Commonwealth University, Richmond.

出版信息

J Natl Cancer Inst. 1993 Sep 15;85(18):1460-74. doi: 10.1093/jnci/85.18.1460.

DOI:10.1093/jnci/85.18.1460
PMID:8360929
Abstract
摘要

相似文献

1
Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.癌症治疗的疗效与成本效益：基于决策分析的资源合理分配
J Natl Cancer Inst. 1993 Sep 15;85(18):1460-74. doi: 10.1093/jnci/85.18.1460.
2
New treatments for advanced cancer: an approach to prioritization.晚期癌症的新疗法：一种优先排序方法。
Br J Cancer. 2000 Nov;83(10):1268-73. doi: 10.1054/bjoc.2000.1406.
3
Rationing in cancer treatment: is the identification of essential cytotoxic drugs feasible?癌症治疗中的资源分配：确定基本细胞毒性药物是否可行？
Ann Oncol. 1999 Apr;10(4):373-4. doi: 10.1023/a:1008353709337.
4
[Cost-effectiveness of cancer drug treatments].[癌症药物治疗的成本效益]
Nihon Rinsho. 2015 Feb;73 Suppl 2:706-12.
5
[Access to cancer care: the cost of treatment matters].[获得癌症治疗：治疗费用至关重要]
Recenti Prog Med. 2014 May;105(5):181-3. doi: 10.1701/1493.16447.
6
Paying for modern cancer care--a global perspective.为现代癌症治疗付费——全球视角
Lancet Oncol. 2007 Sep;8(9):749-51. doi: 10.1016/S1470-2045(07)70250-4.
7
[Allocating resources for cancer control--resolving multicriteria decision-making using the analytic hierarchy process].[为癌症控制分配资源——运用层次分析法解决多标准决策问题]
Magy Onkol. 2007;51(3):197-208. Epub 2007 Oct 7.
8
Age-based rationing in the allocation of health care.
J Aging Health. 2000 Nov;12(4):511-37. doi: 10.1177/089826430001200404.
9
Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.癌症治疗的经济学评估：更多且更优质的研究将带来癌症护理方面更优的选择。
Eur J Cancer. 2006 Nov;42(17):2862-6. doi: 10.1016/j.ejca.2006.08.008. Epub 2006 Sep 27.
10
Cost-effective critical care: cost containment and rationing.具有成本效益的重症监护：成本控制和配给。
Semin Respir Crit Care Med. 2012 Aug;33(4):413-20. doi: 10.1055/s-0032-1322411. Epub 2012 Aug 8.

引用本文的文献

1
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer.三苯氧胺辅助内分泌治疗男性乳腺癌的成本效果分析。
Breast Cancer. 2024 Sep;31(5):917-925. doi: 10.1007/s12282-024-01605-2. Epub 2024 Jun 15.
2
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.对基于mRNA的抗癌治疗的支付意愿：以色列一项条件价值评估研究的结果
Isr J Health Policy Res. 2024 Feb 19;13(1):9. doi: 10.1186/s13584-024-00594-z.
3
Controversies on the management of clinical situations with low therapeutic effectiveness in oncology.
肿瘤学中治疗效果低的临床情况处理的争议。
Clin Transl Oncol. 2010 Jul;12(7):493-8. doi: 10.1007/s12094-010-0542-4.
4
Prognosis without treatment as a modifier in health economic assessments.作为健康经济评估中一项修正因素的未经治疗的预后情况。
BMJ. 2005 Jun 11;330(7504):1382-4. doi: 10.1136/bmj.330.7504.1382.
5
Management and costs of treating lung cancer patients in a university hospital.大学医院中肺癌患者的治疗管理与费用
Pharmacoeconomics. 2004;22(7):435-44. doi: 10.2165/00019053-200422070-00003.
6
Oral cancer treatment costs in Greece and the effect of advanced disease.希腊口腔癌的治疗费用及晚期疾病的影响。
BMC Public Health. 2002 Jul 19;2:12. doi: 10.1186/1471-2458-2-12.
7
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.肝移植等待名单期间肝细胞癌辅助治疗的成本效益
Gut. 2002 Jan;50(1):123-8. doi: 10.1136/gut.50.1.123.
8
Economic analysis of randomized, controlled trials.随机对照试验的经济分析
Curr Oncol Rep. 2001 Sep;3(5):396-403. doi: 10.1007/s11912-001-0025-4.
9
Decision analysis for the cost-effective management of recurrent colorectal cancer.复发性结直肠癌成本效益管理的决策分析
Ann Surg. 2001 Mar;233(3):310-9. doi: 10.1097/00000658-200103000-00003.
10
Therapeutic options in the treatment of multiple myeloma: pharmacoeconomic and quality-of-life considerations.多发性骨髓瘤治疗中的治疗选择：药物经济学及生活质量考量
Pharmacoeconomics. 1999 Oct;16(4):329-41. doi: 10.2165/00019053-199916040-00002.